Skip to content

Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.

Stocks & Finance

The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.


Source: MarketWatch Top Stories — This article was automatically imported from the source. Read full article at original source →

MA
Originally published by MarketWatch Top Stories marketwatch.com
Visit original article

Gram Slattery

Leave a Comment